|
Franklin Lakes, NJ (April 03, 1998) -- Becton Dickinson and Company (NYSE:BDX) announced today that it has completed its acquisition of Ohmeda's Medical Devices Division from The BOC Group. The purchase price for the transaction was $452 million dollars. The acquisition will be part of Becton Dickinson's worldwide infusion therapy business.
|